SCHEMBL15099362

SCHEMBL15099362

CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(N)c4)c3c2)o1

nearest known ligand 0.87

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
EGFR P00533 16/20 0.87
ERBB2 P04626 14/20 0.87
ABCB11 O95342 2/20 0.87
MEN1 O00255 1/20 0.87
PIK3C2B O00750 1/20 0.87
MAP2K7 O14733 1/20 0.87
RIPK2 O43353 1/20 0.87
PIK3C2G O75747 1/20 0.87
STK10 O94804 1/20 0.87
ABL1 P00519 1/20 0.87
INSR P06213 1/20 0.87
RET P07949 1/20 0.87
CYP3A4 P08684 1/20 0.87
PDGFRB P09619 1/20 0.87
SRC P12931 1/20 0.87
CYP3A5 P20815 1/20 0.87
ERBB3 P21860 1/20 0.87
CDK2 P24941 1/20 0.87
KMT2A Q03164 1/20 0.87
KCNH2 Q12809 1/20 0.87

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2101983 0.94 EGFR (0.87) EGFRERBB2ABCB11MEN1PIK3C2B
SCHEMBL18211401 0.94 EGFR (0.86) EGFRERBB2ABCB11MEN1PIK3C2B
SCHEMBL13894728 0.94 EGFR (0.86) EGFRERBB2ABCB11MEN1PIK3C2B
Lapatinib SCHEMBL29351024 0.93 EGFR (1.00) EGFRERBB2ABCB11MEN1PIK3C2B
SCHEMBL2102732 0.93 EGFR (1.00) EGFRERBB2ABCB11MEN1PIK3C2B
SCHEMBL9975775 0.93 EGFR (0.85) EGFRERBB2ABCB11MEN1PIK3C2B
Lapatinib SCHEMBL29464189 0.93 EGFR (1.00) EGFRERBB2ABCB11MEN1PIK3C2B
Lapatinib SCHEMBL16766960 0.93 EGFR (1.00) EGFRERBB2ABCB11MEN1PIK3C2B
SCHEMBL114306 0.93 EGFR (0.85) EGFRERBB2ABCB11MEN1PIK3C2B
Lapatinib SCHEMBL8100 0.93 EGFR (1.00) EGFRERBB2ABCB11MEN1PIK3C2B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1824492-B1 Lapatinib for treating breast cancer brain metastases SMITHKLINE BEECHAM CORK LTD (IE) 2013-07-10 EP disclosed